| FTV |
Report |
Adjusted diluted EPS |
BEAT |
pred ~$0.72 vs. cons $0.70 |
MEDIUM |
| FTV |
Report |
Revenue |
BEAT |
pred ~$1.11B vs. cons $1.09B |
MEDIUM |
| FTV |
Report |
Core revenue growth |
BEAT |
pred ~4.1% vs. cons 3.6% |
MEDIUM |
| FTV |
Guide |
FY26 adjusted diluted EPS guidance |
UNCHANGED |
guide ~$2.95 midpoint vs. cons $2.96 (FY26) |
HIGH |
| FTV |
Guide |
Q3 adjusted diluted EPS outlook |
LOWER |
guide ~$0.70 vs. cons $0.73 (Q3 2026) |
MEDIUM |
| FTV |
Guide |
FY26 core revenue growth outlook |
UNCHANGED |
guide ~2.8% midpoint vs. cons 2.8% (FY26) |
MEDIUM |
| FTV |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| FTV |
Return |
5-day cumulative residual |
-3.0% (FADE) |
A modest Q2 beat of ~$0.02 EPS and ~$0.02B revenue is likely outweighed by FY26 EPS guidance held near a ~$2.95 midpoint and a Q3 EPS setup of ~$0.70 versus ~$0.73 consensus; that out-period shortfall implies downward estimate revisions despite solid organic growth. |
MEDIUM |